![Alex Fässler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alex Fässler
Operationeel Directeur bij Targimmune Therapeutics AG
Vermogen: 3 M $ op 31-05-2024
Actieve functies van Alex Fässler
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Targimmune Therapeutics AG
![]() Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Operationeel Directeur | - | - |
Loopbaan van Alex Fässler
Eerdere bekende functies van Alex Fässler
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Bachem AG
![]() Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01-01-1998 | - |
BACHEM HOLDING AG | Operationeel Directeur | 01-01-1998 | - |
Opleiding van Alex Fässler
Swiss Federal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 4 |
Duitsland | 2 |
Operationeel
Chief Operating Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Bachem AG
![]() Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Targimmune Therapeutics AG
![]() Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Beurs
- Insiders
- Alex Fässler
- Ervaring